Cosmetic dentistry is dental care that improves the appearance of your teeth and smile. A cosmetic dentist can whiten your teeth, straighten them, or improve their shape. They can also replace missing ...

You're reading Part 5 of Coercive Care, a yearlong examination of the denial of reproductive autonomy for people with sickle cell disease. ST. LOUIS — All morning, nurses had been coming in ...

Petro Gazz's Brooke Van Sickle outplays returning Alas Pilipinas and Choco Mucho star Sisi Rondina, while Faith Nisperos-led Akari trumps Galeries and debuting top rookie Julia Coronel to kick off ...

The health of Mr Bayley, who had sickle cell disease, a delusional disorder, and epilepsy, began to deteriorate after he was restrained, and he repeatedly told prison workers that he was ...

Living with sickle cell disease is not a proverbial bed of roses; instead, it’s a journey of twists and turns. Yet I’m grateful for the experience. It’s imparted invaluable life lessons that have ...

Beam Therapeutics, based in Cambridge, Mass., released early clinical data from its first trial for patients with sickle cell disease that employed a gene editing tool, known as CRISPR.

Beam Ther­a­peu­tics gave an ini­tial look at the first hand­ful of pa­tients who re­ceived its ex­per­i­men­tal gene-edit­ed treat­ment for sick­le cell dis­ease.

No­vo Nordisk’s once-a-day sick­le cell dis­ease drug etavopi­vat cut the rate of pain crises in a year­long mid-stage study.

Beam’s medicine uses a technology known as base editing to activate a gene in stem cells collected from people with sickle cell disease, an inherited blood condition that can cause debilitating pain ...

A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals of effective gene editing.

It also requested additional evidence regarding covered services for sickle cell disease and hemophilia. 6. Lastly, CMS finalized several rules related to dental services provided at RHCs and FQHCs, ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, but a patient death underscores the need for less-toxic preconditioning ...